ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ATR | ATR serine/threonine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
BAG1 | BCL2-associated athanogene | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BARD1 | BRCA1 associated RING domain 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Mixed |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BCL3 | B-cell CLL/lymphoma 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BCOR | BCL6 corepressor | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
BIRC2 | Baculoviral IAP repeat containing 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
BLMH | Bleomycin hydrolase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BRD4 | Bromodomain containing 4 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
BRE | Brain and reproductive organ-expressed (TNFRSF1A modulator) | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAMTA1 | Calmodulin binding transcription activator 1 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CASP1 | Caspase 1, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CAST | Calpastatin | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBFA2T3 | Core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CBLB | Cbl proto-oncogene B, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCAR1 | Cell division cycle and apoptosis regulator 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCNA2 | Cyclin A2 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |